Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05087303 · ClinicalTrials.gov registry record · NA
Telemedicine for Children With Sickle Cell Disease
A NA study of Anemia, Sickle Cell, sponsored by Indiana University.
- Active
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT05087303 is a NA study of Anemia, Sickle Cell that is active but no longer recruiting, run by Indiana University. The registered enrollment target is 24 participants, below the 117-participant average among 17 other Anemia, Sickle Cell trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05087303, a NA study of Anemia, Sickle Cell, is active but no longer recruiting, sponsored by Indiana University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to learn more about how the use of two different types of telemedicine (distance medical care) can address barriers to receiving comprehensive sickle cell care, and whether care can be improved. Aim 1: Adapt two telemedicine models (i.e., hub-and-spoke; direct-to-consumer) for use with children with SCD using caregiver input from our preliminary K12 work. Aim 2: Demonstrate the feasibility of the telemedicine models developed in Aim 1 as the models undergo successive stakeholder refinement during use in actual clinical care. Aim 3: Evaluate the effectiveness of the refined models from Aim 2 in a pre/post study by assessing (a) process of care measures, (b) provider satisfaction, (c) caregiver/patient-centered outcomes, and (d) clinical outcomes and healthcare utilization.
Conditions Studied
Interventions
- OTHER Types of Telemedicine Delivery Models
Study Locations (1)
Indiana
- Indiana University - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2022-11-23 |
| Est. Completion | 2026-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05087303
The ClinicalTrials.gov registry entry for NCT05087303 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 117-participant average among 17 other Anemia, Sickle Cell trials with a reported enrollment target (79% lower). The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Anemia, Sickle Cell appearing as the primary indexed condition, and to 1 intervention - of which Types of Telemedicine Delivery Models is the first listed.
NCT05087303 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.
Frequently Asked Questions
What is clinical trial NCT05087303 about?
NCT05087303 is a clinical study titled "Telemedicine for Children With Sickle Cell Disease". The purpose of this study is to learn more about how the use of two different types of telemedicine (distance medical care) can address barriers to receiving comprehensive sickle cell care, and whether care can be improved. Aim 1: Adapt two telemedicine models (i.e., hub-and-spoke; direct-to-consume...
What is the current status of trial NCT05087303?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2022-11-23. Estimated completion is 2026-04-30.
What conditions does trial NCT05087303 study?
This clinical trial studies the following conditions: Anemia, Sickle Cell.
What interventions are being tested in trial NCT05087303?
The interventions under investigation include: Types of Telemedicine Delivery Models (OTHER).
Who is sponsoring clinical trial NCT05087303?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05087303 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anemia, Sickle Cell
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Metabolic and Hemodynamic Reserve in Pediatric SCA
RECRUITING · NA
-
Therapeutic Response Evaluation and Adherence Trial (TREAT)
ACTIVE NOT RECRUITING · NA
-
Feasibility and Efficacy of a Home-based, Computerized Cognitive Training Program in Pediatric Sickle Cell Disease
COMPLETED · NA
-
Effectiveness of a Computerized Tool (PAINRelieveIt) to Help Manage Pain Related to Sickle Cell Disease
COMPLETED · NA
-
Implementing an Individualized Pain Plan (IPP) for ED Treatment of VOE's in Sickle Cell Disease
COMPLETED · NA
-
MBSR for Pain Catastrophizing in SCD
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.